Suppr超能文献

大流行后针对 SARS-CoV-2 的记忆 T 细胞反应具有持久性、广泛靶向性和对高度突变的 BA.2.86 变体的交叉反应性。

Post-pandemic memory T cell response to SARS-CoV-2 is durable, broadly targeted, and cross-reactive to the hypermutated BA.2.86 variant.

机构信息

Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa; Division of Medical Virology, Department of Pathology, University of Cape Town, Cape Town, South Africa.

Department of Medicine, University of Cape Town and Groote Schuur Hospital, Cape Town, South Africa; Cape Heart Institute, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa; South African Medical Research Council Extramural Unit on Intersection of Non-communicable Disease and Infectious Diseases, University of Cape Town, Cape Town, South Africa.

出版信息

Cell Host Microbe. 2024 Feb 14;32(2):162-169.e3. doi: 10.1016/j.chom.2023.12.003. Epub 2024 Jan 10.

Abstract

Ongoing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) evolution has given rise to recombinant Omicron lineages that dominate globally (XBB.1), as well as the emergence of hypermutated variants (BA.2.86). In this context, durable and cross-reactive T cell immune memory is critical for continued protection against severe COVID-19. We examined T cell responses to SARS-CoV-2 approximately 1.5 years since Omicron first emerged. We describe sustained CD4+ and CD8+ spike-specific T cell memory responses in healthcare workers in South Africa (n = 39) who were vaccinated and experienced at least one SARS-CoV-2 infection. Spike-specific T cells are highly cross-reactive with all Omicron variants tested, including BA.2.86. Abundant nucleocapsid and membrane-specific T cells are detectable in most participants. The bulk of SARS-CoV-2-specific T cell responses have an early-differentiated phenotype, explaining their persistent nature. Overall, hybrid immunity leads to the accumulation of spike and non-spike T cells evident 3.5 years after the start of the pandemic, with preserved recognition of highly mutated SARS-CoV-2 variants.

摘要

持续的严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)进化产生了重组奥密克戎谱系,这些谱系在全球占主导地位(XBB.1),以及高突变变体(BA.2.86)的出现。在这种情况下,持久和交叉反应的 T 细胞免疫记忆对于持续预防严重的 COVID-19 至关重要。我们大约在奥密克戎首次出现后 1.5 年检查了对 SARS-CoV-2 的 T 细胞反应。我们描述了南非(n=39)的医疗保健工作者在接种疫苗并经历至少一次 SARS-CoV-2 感染后,对刺突蛋白具有持续的 CD4+和 CD8+特异性 T 细胞记忆反应。刺突蛋白特异性 T 细胞与所有测试的奥密克戎变体高度交叉反应,包括 BA.2.86。大多数参与者都可检测到丰富的核衣壳和膜特异性 T 细胞。大量的 SARS-CoV-2 特异性 T 细胞反应具有早期分化的表型,这解释了它们的持久性。总体而言,混合免疫导致在大流行开始 3.5 年后积累了刺突蛋白和非刺突蛋白 T 细胞,对高度突变的 SARS-CoV-2 变体仍保持识别能力。

相似文献

10
Limited Recognition of Highly Conserved Regions of SARS-CoV-2.有限识别 SARS-CoV-2 的高度保守区域。
Microbiol Spectr. 2022 Feb 23;10(1):e0278021. doi: 10.1128/spectrum.02780-21.

引用本文的文献

本文引用的文献

2
Neutralization escape by SARS-CoV-2 Omicron subvariant BA.2.86.奥密克戎变异株 BA.2.86 对 SARS-CoV-2 的中和逃逸
Vaccine. 2023 Nov 13;41(47):6904-6909. doi: 10.1016/j.vaccine.2023.10.051. Epub 2023 Oct 21.
3
SARS-CoV-2 evolution in the Omicron era.奥密克戎时代的 SARS-CoV-2 进化。
Nat Microbiol. 2023 Nov;8(11):1952-1959. doi: 10.1038/s41564-023-01504-w. Epub 2023 Oct 16.
4
Variant-adapted COVID-19 booster vaccines.变异株适应的 COVID-19 加强疫苗。
Science. 2023 Oct 13;382(6667):157-159. doi: 10.1126/science.adh2712. Epub 2023 Oct 12.
6
Antigenicity and infectivity characterisation of SARS-CoV-2 BA.2.86.新型冠状病毒BA.2.86的抗原性和感染性特征
Lancet Infect Dis. 2023 Nov;23(11):e457-e459. doi: 10.1016/S1473-3099(23)00573-X. Epub 2023 Sep 19.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验